Alan B. Sandler
CIK 1835966 · Chief Medical Officer · last filed 2026-01-21
Alan B. Sandler is a Chief Medical Officer who has filed 17 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for ALXO, was dated Jan 21, 2026. Current disclosed insider exposure totals $494.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$494.8K
4
17
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALXO | Chief Medical Officer | — | $1.58 | — | $0 | 5 | 2026-01-21 |
| Elevation Oncology, Inc. (ELEV) Delisted | Director | — | $0.36 | — | $0 | 4 | 2025-07-24 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Chief Medical Officer | 17,021 | $58.70 | $999.1K | $0 | 4 | 2024-01-23 |
| ZLAB | Head of Global Dev., Oncology | 28,985 | $17.07 | $494.8K | $0 | 4 | 2022-06-27 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-21 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2025-07-24 | Elevation Oncology, Inc. (ELEV) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-09 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-04-15 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2025-01-23 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2024-11-19 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2024-08-07 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-04 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-23 | Mirati Therapeutics, Inc. (MRTX) Delisted | Disp (D) | −79,865 | $0 | EDGAR |